Author:
Hsu Tzu-Sheng,Chen Chinpiao,Lee Pei-Ting,Chiu Shu-Jun,Liu Huei-Fang,Tsai Chih-Chien,Chao Jui-I
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference36 articles.
1. Yoon E, Choi HY, Shin KJ, Yoo KH, Chi DI, Kim DJ (2000) The regioselectivity in the reaction of 6,7-dihaloquinoline-5,8-diones with amine nucleophiles in various solvents. Tetrahedron Lett 41:7475–7480
2. Boger DL, Yasuda M, Mitscher LA, Drake SD, Kitos PA, Thompson SC (1987) Streptonigrin and lavendamycin partial structures. Probes for the minimum, potent pharmacophore of streptonigrin, lavendamycin, and synthetic quinoline-5,8-diones. J Med Chem 30:1918–1928
3. Pu L, Amoscato AA, Bier ME, Lazo JS (2002) Dual G1 and G2 phase inhibition by a novel, selective Cdc25 inhibitor 7-chloro-6-(2-morpholin-4-ylethylamino)-quinoline-5,8-dione. J Biol Chem 277:46877–46885
4. Fang Y, Linardic CM, Richardson DA, Cai W, Behforouz M, Abraham RT (2003) Characterization of the cytotoxic activities of novel analogues of the antitumor agent, lavendamycin. Mol Cancer Ther 2:517–526
5. Lee YS, Wurster RD (1995) Mechanism of potentiation of LY83583-induced growth inhibition by sodium nitroprusside in human brain tumor cells. Cancer Chemother Pharmacol 36:341–344
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献